Retrospective analysis reveals similar 90-day readmission rates for solitary and multifocal spondylodiscitis, highlighting risk factors.
Background: Spondylodiscitis is a growing infectious condition with significant morbidity. The impact of multifocal involvement remains understudied. This study compared 90-day all-cause readmission rates between patients with solitary versus multifocal spondylodiscitis and identified the associated risk factors. Methods: A retrospective analysis of the 2020 Nationwide Readmissions Database was conducted. Adult patients with primary spondylodiscitis were identified using ICD-10 codes and categorized into solitary or multifocal involvement groups. Demographic, clinical, and surgical data were extracted. Descriptive statistics and multivariate logistic regression were performed. Results: Of 6132 patients, 585 (9.6%) had multifocal disease. Multifocal patients were slightly younger (58.9 vs. 60.3 years; p = 0.049); had longer hospital stays (14.7 vs. 11.4 days; p < 0.001), time to readmission (p < 0.001); and surgery was more common (p = 0.003). Ninety-day readmission rates were similar (35.6% vs. 34.9%; p = 0.766). Type 2 diabetes was the only comorbidity significantly associated with multifocal disease (p = 0.020) and independently predicted readmission (aOR 1.236). Surgery and longer length of stay were protective (aOR 0.743; 0.0990). Conclusions: Multifocal spondylodiscitis is relatively common but not an independent risk factor for readmission. Readmission rates of both cohorts were similar. Surgery and prolonged hospitalization may reduce readmission risk.
No takes yet. Share an insight, caveat, or question.
Gerstmeyer et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: